Skip to main content

Advertisement

Log in

Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc. 1957;147:258–267. doi:10.1098/rspb.1957.0048.

    Article  CAS  Google Scholar 

  2. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management and treatment of hepatitis C American association of liver disease. Hepatology. 2004;39:1147. doi:10.1002/hep.20119.

    Article  PubMed  Google Scholar 

  3. Jacobson IM. Understanding the interferon molecule. Gastroenterol Hepatol. 2008;4:3–7.

    Google Scholar 

  4. Monzani F, Caraccio N, Dardano A, Ferrannini E. Thyroid autoimmunity and dysfunction associated with type I interferon therapy. Clin Exp Med. 2004;3:199–210. doi:10.1007/s10238-004-0026-3.

    Article  CAS  PubMed  Google Scholar 

  5. Okanoue T, Sakamoto S, Itoh Y, et al. Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol. 1996;25(3):283–291. doi:10.1016/S0168-8278(96)80113-9.

    Article  CAS  PubMed  Google Scholar 

  6. Fabris P, Betterle C, Greggio NA, et al. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol. 1998;28(3):514–517. doi:10.1016/S0168-8278(98)80328-0.

    Article  CAS  PubMed  Google Scholar 

  7. Cozzolongo R, Betterle C, Fabris P, Paola Albergoni M, Lanzilotta E, Manghisi OG. Onset of type 1 diabetes mellitus during peginterferon alpha-2b plus ribavirin treatment for chronic hepatitis C. Eur J Gastroenterol Hepatol. 2006;18(6):689–692. doi:10.1097/00042737-200606000-00018.

    Article  PubMed  Google Scholar 

  8. Schreuder TC, Gelderblom HC, Weegink CJ, et al. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection. Liver Int. 2008;28(1):39–46.

    CAS  PubMed  Google Scholar 

  9. Ward DL, Bing-You RG. Autoimmune thyroid dysfunction induced by interferon-alpha treatment for chronic hepatitis C: screening and monitoring recommendations. Endocr Pract. 2001;7(1):52–58.

    CAS  PubMed  Google Scholar 

  10. Wilson LE, Widman D, Dikman SH, Gorevic PD. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection. Semin Arthritis Rheum. 2002;32(3):163–173. doi:10.1053/sarh.2002.37277.

    Article  PubMed  Google Scholar 

  11. Unsworth J, Hutchins P, Mitchell J, et al. Flat small intestinal mucosa and autoantibodies against the gut epithelium. J Pediatr Gastroenterol Nutr. 1982;1:503–513. doi:10.1097/00005176-198212000-00010.

    Article  CAS  PubMed  Google Scholar 

  12. Akram S, Murray JA, Pardi DS, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol. 2007;5(11):1282–1290. doi:10.1016/j.cgh.2007.05.013.

    Article  PubMed  Google Scholar 

  13. Casis B, Fernandez-Vazquez I, Barnardos E, et al. Autoimmune enteropathy in an adult with autoimmune multisystemic involvement. Scand J Gastroenterol. 2002;37:1012–1016. doi:10.1080/003655202320378185.

    Article  CAS  PubMed  Google Scholar 

  14. Al Khalidi H, Kandel G, Streutker CJ. Enteropathy with loss of enteroendocrine and paneth cells in a patient with immune dysregulation: a case of adult autoimmune enteropathy. Hum Pathol. 2006;37:373–376. doi:10.1016/j.humpath.2005.11.019.

    Article  PubMed  Google Scholar 

  15. Ciccocioppo R, D’Alo S, Di Sabatino A, et al. Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease. Clin Exp Immunol. 2002;128:88–93. doi:10.1046/j.1365-2249.2002.01795.x.

    Article  CAS  PubMed  Google Scholar 

  16. Veress B, Franzen L, Bodin L, et al. Duodenal intraepithelial lymphocyte-count revisited. Scand J Gastroenterol. 2004;39:138–144. doi:10.1080/00365520310007675.

    Article  CAS  PubMed  Google Scholar 

  17. Cuenod B, Brousse N, Goulet O, et al. Classification of intractable diarrhea in infancy using clinical and immunohistological criteria. Gastroenterology. 1990;99:1037–1043.

    CAS  PubMed  Google Scholar 

  18. Leon F, Olivencia P, Rodriguez-Pena R, et al. Clinical and immunological features of adult-onset generalized autoimmune gut disorder. Am J Gastroenterol. 2004;99:1563–1571. doi:10.1111/j.1572-0241.2004.40039.x.

    Article  PubMed  Google Scholar 

  19. Daum S, Sahin E, Jansen A, et al. Adult autoimmune enteropathy treated successfully with tacrolimus. Digestion. 2003;68:86–90. doi:10.1159/000074520.

    Article  CAS  PubMed  Google Scholar 

  20. Oliva-Hemker MM, Loeb DM, Abraham SC, et al. Remission of severe autoimmune enteropathy after treatment with high-dose cyclophosphamide. J Pediatr Gastroenterol Nutr. 2003;36:639–643. doi:10.1097/00005176-200305000-00010.

    Article  PubMed  Google Scholar 

  21. Vanderhoof JA, Young RJ. Autoimmune enteropathy in a child: response to infliximab therapy. J Pediatr Gastroenterol Nutr. 2002;34:312–316. doi:10.1097/00005176-200203000-00018.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to German Gonzalez.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gonzalez, G., Castro, F.P., Berho, M. et al. Autoimmune Enteropathy Associated with Cessation of Interferon-Alpha Therapy in Chronic Hepatitis C. Dig Dis Sci 55, 1490–1493 (2010). https://doi.org/10.1007/s10620-009-0877-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-009-0877-2

Keywords

Navigation